DAXXIFY®
The only long-lasting, peptide-powered frown line treatment.
DAXXIFY®
The only long-lasting, peptide-powered frown line treatment.
DAXXIFY®
Available At
- El Monte
- Huntington Park
- Carson
Overview
We’re one of the first exclusive providers in Los Angeles to offer this innovative treatment. DAXXIFY is FDA approved to help smooth moderate to severe lines between the brows. It is the only long-lasting frown line treatment powered by a peptide with results that last on average 6 months and up to 9 months for some.*
Conventional injectables last 3 – 4 months and require up to 4 treatments a year to maintain results.
Nearly 90% of patients say they wish results lasted longer. With DAXXIFY, you can keep your frown lines smoother for a full year with as few as 2 treatments.*
Source: DAXXIFY
Benefits
Before & After
*At least 50% of patients in clinical studies had no or minor frown lines 6 months after treatment. Between 3% and 5% of patients in clinical studies had no or minor frown lines 9 months after treatment. In other safety studies, between 5% and 17% of patients still had noticeable improvement 9 months later.
FAQ
All frown line treatments require a special ingredient to stabilize botulinum toxin A, the protein responsible for helping smooth moderate to severe frown lines. For instance, BOTOX® Cosmetic uses human serum albumin (HSA), a blood product, as its stabilizer. Dysport®, another frown line treatment, uses HSA as a stabilizer and cow’s milk protein as a protectant.
DAXXIFY is unique because it is the only formulation that uses a novel peptide as a stabilizer and does not contain human or animal byproducts.
- There were no serious treatment-related side effects in clinical trials for DAXXIFYTM
- The active ingredient in DAXXIFYTM is botulinum toxin type A, an ingredient that has been used in frown line treatments for more than 20 years
- 96% of people treated with DAXXIFY were satisfied with their results.†
†96% of patients reported they were satisfied on a 7-point scale when evaluated at 4 weeks in clinical studies.
